BlackRock’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-539,973
| Closed | -$5.42M | – | 5349 |
|
|
2023
Q4 | $5.42M | Sell |
539,973
-19,472
| -3% | -$195K | ﹤0.01% | 3586 |
|
|
2023
Q3 | $1.61M | Buy |
559,445
+42,036
| +8% | +$121K | ﹤0.01% | 4019 |
|
|
2023
Q2 | $1.97M | Sell |
517,409
-38,726
| -7% | -$148K | ﹤0.01% | 3977 |
|
|
2023
Q1 | $1.03M | Sell |
556,135
-421,429
| -43% | -$784K | ﹤0.01% | 4245 |
|
|
2022
Q4 | $2.25M | Buy |
977,564
+22,706
| +2% | +$52.2K | ﹤0.01% | 4013 |
|
|
2022
Q3 | $3.08M | Sell |
954,858
-54,290
| -5% | -$175K | ﹤0.01% | 3893 |
|
|
2022
Q2 | $5.55M | Buy |
1,009,148
+84,517
| +9% | +$465K | ﹤0.01% | 3693 |
|
|
2022
Q1 | $2.15M | Buy |
924,631
+144,940
| +19% | +$338K | ﹤0.01% | 4270 |
|
|
2021
Q4 | $4.71M | Sell |
779,691
-153,768
| -16% | -$929K | ﹤0.01% | 3950 |
|
|
2021
Q3 | $12.9M | Sell |
933,459
-27,076
| -3% | -$376K | ﹤0.01% | 3506 |
|
|
2021
Q2 | $12.5M | Buy |
960,535
+6,077
| +0.6% | +$79K | ﹤0.01% | 3503 |
|
|
2021
Q1 | $14.7M | Buy |
+954,458
| New | +$14.7M | ﹤0.01% | 3295 |
|